Chembio Diagnostic Systems, Inc. of Medford, NY at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

Chembio Diagnostic Systems, Inc.

3661 Horseblock Road, 11763 Medford, NY
USA

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2019 hall map (Hall 3): stand C16-11

Fairground map

MEDICA 2019 fairground map: Hall 3

Our products

Product category: Diagnostic rapid tests

DPP® HIV 1/2 Assay

Chembio has developed a NEXT GENERATION DPP® assay using patented DPP® technology for the rapid detection of HIV 1 and HIV 2 antibodies in oral fluid and all blood matrices. The Chembio DPP® HIV 1/2 Assay is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV 1 and HIV 2. This test is suitable for use in multi-test algorithms that have been established in many countries or as a standalone initial test.

More Less

Product category: Diagnostic rapid tests

DPP® HIV-Syphilis Assay

Chembio Diagnostic Systems has developed the first dual HIV 1/2 and Syphilis Point-of-Care (POC) test utilizing Chembio’s patented Dual Path Platform (DPP®) technology. The Chembio DPP® HIV-Syphilis Assay is a single-use, immunochromatographic, rapid test for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV 1/2) and Treponema pallidum (the causative agent of syphilis) in fingerstick whole blood, venous whole blood, serum, and plasma.

The Chembio DPP® HIV-Syphilis Assay is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV and/or Syphilis. This test is suitable for use in multi-test algorithms designed for the statistical validation of rapid HIV test results.

A unique feature of this kit is Chembio’s new DPP® SampleTainer® bottle which contains a premeasured dilution buffer within a closed vial that also serves as a dropper for performing the assay. Smart, easy and efficient!

More Less

Product category: Diagnostic rapid tests

HIV 1/2 STAT-PAK® Assay

Chembio HIV 1/2 STAT-PAK® tests are easy-to-perform, single-use diagnostic tests for the rapid (15 minutes), visual detection of antibodies to HIV 1 and HIV 2 at point-of-care (POC).

For Use With:
  • Serum
  • Plasma
  • Fingerstick whole blood
  • Venipuncture whole Blood

More Less

Product category: Diagnostic rapid tests

HIV 1/2 STAT-PAK® DIPSTICK Assay

HIV 1/2 STAT-PAK® DIPSTICK tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of antibodies to HIV 1 and HIV 2.

For Use With:
  • Serum
  • Plasma
  • Fingerstick
  • Venipuncture whole blood

More Less

Product category: Diagnostic rapid tests

STAT-VIEW® HIV 1/2 Assay (CE Marked)

Chembio’s STAT-VIEW® HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV

For Use With:
  • Serum
  • Plasma
  • Fingerstick
  • Venipuncture Whole Blood

More Less

Product category: Diagnostic rapid tests

DPP® Syphilis Screen & Confirm Assay (CE Marked)

A rapid point-of-care test that simultaneously and separately detects treponemal and nontreponemal antibodies.

Key Features
  • Innovative: Screen and confirm syphilis infection simultaneously, no need for reflex testing
  • Simple to use: Does not require specialized medical training
  • Actionable: Provides results in as little as 15 minutes, enabling physicians to make treatment decisions
  • Cost effective: Reduces overtreatment rate and cost burden; eliminates repeated visits to healthcare professionals

More Less

Product category: Diagnostic rapid tests

DPP® Zika IgM/IgG System (CE-Marked)

Single-use point-of-care (POC) assays for use with reader for the discrete, semi-quantitative detection of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to Zika Virus.

For Use With:
  • Serum
  • Plasma
  • Fingerstick whole blood
  • Venipuncture whole blood

More Less

Product category: Diagnostic rapid tests

DPP® Zika IgM System

For the detection of Zika virus IgM antibodies in fingerstick whole blood, EDTA venous whole blood, EDTA plasma and serum

Key features
  • Fast: Provides results in as little as 15 minutes
  • Flexible: Detects Zika virus IgM antibodies from 8 days up to 12 weeks
  • Easy to use: Provides objective results using simple, handheld digital reader (DPP® Micro Reader)
Product performance
Wide testing window
DPP® Zika IgM Assay System detected Zika antibodies as early as day 8 and reliably detected for approximately 12 weeks1

More Less

About us

Company details

We Improve Lives—that’s what drives us. It’s what makes us better, more innovative, more compelled to work harder. What we do is develop superior point-of-care rapid testing solutions for healthcare providers around the world; what we help create is healthier lives and communities.

Our Products meet the highest standards for accuracy and superior performance to help prevent the spread of infectious diseases. Our innovative solutions, like the Chembio Dual Path Platform (DPP®), make POC testing faster, more accurate, and more cost effective. And all of Chembio’s products have been designed, developed, tested, and manufactured in our Medford, NY, USA facility.

Our People—are what makes Chembio. Chembio has a solid core of loyal, experienced, professional employees, and that creates loyal customers.
These are our values.

More Less